Disruptions from the COVID-19 pandemic have caused hardship across the world, with the poorest people in India hit particularly hard. With the objective of helping to alleviate food insecurity, the Dr. Majeed Foundation gave 5,500 rice bags of 10 kilo each to the people of Magadi, Karnataka on September 24, 2020. The Foundation is the philanthropic organization started and funded by the Sami-Sabinsa Group founder and chairman, Dr. Muhammed Majeed.
Sabinsa Granted Patent on a Combination of the Company’s Ingredients for Hair Growth in Mexico
- Details
- Press Release
- 541

Sabinsa, the leading nutraceutical ingredients company with patents throughout the world, has expanded its portfolio of intellectual property with a new patent granted in Mexico for Saberry®.
Sabinsa Publishes Study Evaluating Hair Health Serum in Trial of Adults Hair Thinning and Loss
- Details
- Press Release
- 507

A clinical study on Sabinsa’s patented hair serum formulation was found to significantly improve hair fall and thinning. “Clinical Study to Evaluate the Efficacy and Safety of a Hair Serum Product in Healthy Adult Male and Female Volunteers with Hair Fall” by Majeed M, Majeed S, Nagabhushanam K, Mundkur L, Neupane P and Shah K was published in Clinical, Cosmetic and Investigational Dermatology (2020:13 691–700).
Research on Sabinsa’s Cosmeceutical LactoSporin® Showing Anti-Acne Benefits among the First Published Human Clinical Studies Examining a Probiotic Metabolite
- Details
- Press Release
- 527

Additional In Vitro Study Examined Anti-Aging Properties
As Sabinsa’s R&D Scientists expanded their understanding of probiotics, and developed new products based upon that increased knowledge, it was inevitable that published studies would soon follow. Sabinsa has recently published its first human clinical study on anti-acne benefits of LactoSporin®, the probiotic metabolite derived from the highly regarded probiotic LactoSpore®. A second published study, in vitro, demonstrated the anti-aging potential of this topical ingredient. Together, the research supports the use of LactoSporin for skin care applications.
Sabinsa Issues Cease & Desist Letter Regarding Mischaracterized Amla Extracts to Applied Food Sciences
- Details
- Press Release
- 605

Sabinsa has sent a cease & desist letter to Applied Food Sciences (AFS) for making claims of high levels of natural vitamin C in that company’s branded amla (Emblica officinalis) extract. The letter states that AFS’s representations that the product contains 25% vitamin C derived from amla (which is not technically possible) “mislead and deceive consumers and constitute unfair competition and false advertising under applicable law.”
Sabinsa Introduces LivLonga®, a New Patented Combination for Liver Support
- Details
- Press Release
- 694

Sabinsa, the pioneer of ingredients conceived by modern science drawing from traditional Ayurvedic knowledge, announces a new combination to support healthy liver function, LivLonga®, giving a boost to a category teeming with dated, generic products.
Sabinsa Earns Non-Gmo Project Verification For Eleven Key Ingredients
- Details
- Press Release
- 669

Sabinsa is pleased to announce that several of the company’s ingredients have been Non-GMO Project Verified, adding to the value the end-user finds in Sabinsa’s transparency and commitment to natural, sustainable, and Non-GMO ingredients.
Sabinsa’s Curcumin C3 Complex® With BioPerine® Shown To Improve Cytokine Levels
- Details
- Press Release
- 757

Sabinsa’s Curcumin C3 Complex®, the #1 clinically studied curcumin brand on the market, is the subject of a recently published study on its effect, combined with BioPerine®, on serum cytokine concentrations. Effects of supplementation with curcuminoids on serum adipokines in critically ill patients: a randomized double-blind placebo-controlled trial was published in the peer-reviewed journal Phytotherapy Research.
Dr. Majeed Foundation Makes Significant Contributions to Combat COVID-19 in India, Including $1.32 Million to PM CARES Fund
- Details
- Press Release
- 761

Sabinsa founder and chairman Dr. Muhammed Majeed presents check to PM CARES Fund.
From Left to Right: Ms. Neeraja Shetty, CEO and Director, Sami Labs; Dr. Muhammed Majeed, Founder and Chairman, Sami-Sabinsa Group; Dr. Anju Majeed, Director and Sr. Scientist, Sami Labs; and Shaheen Majeed, President Worldwide, Sabinsa and Director, Sami Labs
Sabinsa Warns Industry Against Mischaracterized Amla Extracts
- Details
- Press Release
- 787

Material Claiming Naturally High Amounts of Vitamin C IRMS-Tested, Establishing It as Non-Amla, Fermentation Source
Sabinsa, which alerted the industry to synthetic curcumin masquerading as natural source turmeric, has identified mischaracterized amla (Emblica officinalis) extract with claims of high levels of natural vitamin C for sale in the marketplace.
© 2021 Sabinsa. All Rights Reserved | Powered by Edkal Technologies | Disclaimer